EDGAR Filing Documents for 0001193125-09-042557

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-09-042557

Filing Date

2009-03-02

Accepted

2009-03-02 16:15:30

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	976406
2	AMENDMENT NO. 1 TO SEPARATION AND DISTRIBUTION AGREEMENT	dex22.htm	EX-2.2	10312
3	AMENDMENT NO. 2 TO PATENT LICENSING MASTER AGREEMENT	dex1026.htm	EX-10.26	35658
4	PATENT LICENSE AGREEMENT - MEDIMMUNE INC.	dex1028.htm	EX-10.28	58014
5	PATENT LICENSE AGREEMENT - ELAN INTERNATIONAL SERVICES LTD.	dex1029.htm	EX-10.29	54071
6	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	5265
7	CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A)	dex311.htm	EX-31.1	6423
8	CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A)	dex312.htm	EX-31.2	6151
9	CERTIFICATION BY THE PEO AND THE PFO	dex321.htm	EX-32.1	3974
10	GRAPHIC	g95425g87c78.jpg	GRAPHIC	6680
11	GRAPHIC	g95425g95e97.jpg	GRAPHIC	39141
	Complete submission text file	0001193125-09-042557.txt		1221215

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451

Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500

PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)